Women have a 20% lifetime risk of stroke. In addition, the majority of stroke-related deaths occur in women. Reducing the burden of stroke in women through prevention would positively affect public health. Unfortunately, most of the data used to develop specifi c evidence-based guidelines for stroke prevention in women were derived from coronary heart disease studies. Stroke was a secondary and less common outcome, if it was included at all. In addition, women have traditionally been underrepresented in stroke prevention trial cohorts. Stroke prevention in women offers many challenges, not only related to data extrapolated from clinical trials primarily composed of men, but also because physicians may underestimate cardiovascular risk in women, and therefore prevention strategies may not be appropriately undertaken. The opportunities to improve stroke prevention in women include increasing patient and physician awareness of risk and optimizing management of key modifi able risk factors (eg, hypertension, hyperlipidemia, physical inactivity, obesity, and diabetes).
Introduction
Stroke is a devastating and disabling disease, impacting about 780,000 people in the United States annually [ 1 ] . Stroke is also preventable; therefore, developing prevention strategies requires an in-depth examination of the population at risk. Women make up about half the population at age 50, but the ratio of women to men increases with each decade to a ratio of 2.70 at age 90 [ 2 ] . As a result of the larger number of women in older age groups, an excess of stroke deaths occur in women, a statistic that will increase as the population ages. The prevalence of stroke is lower in women than men until the ages of 75
[ 3 ] to 85 [ 4 ] , depending on where the data were collected. However, recent studies suggest that there is a midlife surge in stroke among women at higher rates than men [ 5 ] . The reasons for this surge are not understood, but may be related to increasing blood pressure, cholesterol, and blood glucose at higher rates in women during ages 35 to 54 compared with men of the same age [ 5 ] . In addition to this potential increase during midlife, other risk factors are unique to women and can impact prevention. The purpose of this review is to discuss risk prevention in terms of the challenges and opportunities (summarized in Table 1 ) to reduce the burden of stroke in women.
Challenges in Stroke Prevention for Women

Gender disparities in prevention management
Women traditionally have been screened and treated for cardiovascular disease (CVD) less aggressively than men [ 6 ] . A study of physician awareness and application of evidence-based cardiovascular guidelines provided some insight into why this occurs. Questionnaires with patient scenarios were completed by primary care physicians, cardiologists, and ob/gyns. Participating physicians were less aware of the CVD guidelines for women (64%) than they were for the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) (86%) and National Cholesterol Education Program/Adult Treatment Panel (NCEP ATP III) (89%) recommendations [ 7 ] . Physicians older than 50 years were more likely to be aware of these guidelines than those younger than 50 years [ 7 ] . Some gender disparities were obvious, but the most important related to risk assignment. Specifi cally, intermediate-risk women were more often incorrectly assigned to a low-risk category and this lower risk assignment was associated with less aggressive recommendations for lifestyle and prevention treatment [ 8• ]. In addition, fewer than one in fi ve physicians were aware that more women than men die from CVD each year [ 8• ].
Consistent with these physicians' perceptions, a recent national study evaluating several cardiovascular quality indicators in the ambulatory setting showed that women with a history of CVD and diabetes were less likely to have met low-density lipoprotein (LDL) cholesterol target levels (< 100 mg/dL) although women achieved target blood pressures more often than men [ 6 ] . Therefore, many challenges in improving prevention quality of care for women may be associated with physician and patient awareness of risk factors and preventive strategies. Almost no studies have been done examining gender disparities in secondary prevention in stroke patients. In this article, the remaining prevention challenges are presented in the context of individual risk factors.
Hypertension
High blood pressure is one of the most important modifi able risk factors for stroke. From a secondary prevention perspective, awareness and treatment of hypertension is important because women with a history of stroke are more likely than men to have hypertension [9] [10] [11] [12] [13] . The major challenge is that 30% of patients do not know they have hypertension, 40% are not treated, and more than 60% do not have adequate blood pressure control [ 14 ] . In addition, ob/gyns (who frequently function as primary providers for women) are signifi cantly less aware of the most recent JNC-7 blood pressure management guidelines, and are less likely than primary care providers or cardiologists to recommend blood pressure therapy in addition to β -blockers when blood pressure is 140/95 mm Hg [ 8 ]. In general, primary care physicians, cardiologists, and ob/gyns are all less likely to follow the JNC-7 guideline for the use of diuretics as fi rst-line treatment for hypertension [ 8 ] . Other studies of ambulatory blood pressure management reported that of those with hypertension, women aged 65 to 80 were 38% less likely than men to have adequate blood pressure control (OR 0.62; 95% CI, 0.45-0.85), and 40% less likely to receive β -blockers (OR 0.60; 95% CI, 0.36-0.99) [ 15 ] .
Even very high-risk women (ie, those who have had a stroke) may have poor blood pressure control. A secondary analysis of the Women Estrogen Stroke Trial (WEST), a trial of 17 β -estradiol versus placebo in women with stroke or transient ischemic attack [ 16 ] , showed that about 1 month after stroke, only 44% of women had blood pressure values within national guidelines (JNC 6 when this analysis was published) [ 17 ] . Of those outside the guideline measurements, 55% were still beyond the guideline at follow-up. The clinical predictors of severely elevated blood pressure (systolic blood pressure > 160 mm Hg or diastolic blood pressure > 100 mm Hg) included a history of hypertension and education less than college, whereas impaired mental status protected against elevated blood pressures [ 17 ] . This analysis demonstrated that even women participating in a secondary stroke prevention trial had poorly controlled blood pressure, in part because hypertension was undiagnosed.
In summary, the challenges for hypertension management are as follows: patients with hypertension, but especially women, are not achieving adequate blood pressure control in the ambulatory setting; women who primarily receive their general medical care from ob/gyns may not receive the guideline-recommended antihypertensive therapy; and women who have already had a stroke and are at the highest risk for recurrence are poorly managed, in part because of under-recognition of the diagnosis.
Cholesterol management
Lowering cholesterol is important because high levels have been associated with mortality in women. As shown Table 1 
. Challenges and opportunities for stroke prevention in women Challenges Opportunities
Underestimation of CVD risk in women by treating physicians Improve physician awareness and adherence of the CVD prevention guidelines for women Women are infrequently counseled by physicians to engage in physical activity according to the guidelines High-risk women do not achieve target lipid profi les and blood pressures Improve physician adherence to guidelines for stroke primary and secondary prevention-JNC 7 and NCEP-ATP III; improve patient adherence to medication recommendations Physical inactivity is a signifi cant risk factor for stroke in women, regardless of weight status Exercise capacity can be assessed using a nomogram that predicts risk of cardiac and all-cause death in women CVD risk increases as women transition through menopause; stroke prevalence may be increasing faster in women than men in this age group More careful surveillance of CVD risk factors in women transitioning through menopause or recently postmenopause
Women with a history of preeclampsia have a higher risk of hypertension and stroke later in life
Research focused on identifying women at high risk for stroke, and careful surveillance for development of hypertension Atrial fi brillation is more common in women with stroke, but many women may not be prescribed anticoagulation due to fall risk Carefully assess fall risk, but risk of ischemic stroke in selected women may be even higher than risk of hemorrhagic complications of falls CVD-cardiovascular disease; JNC 7-Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; NCEP-ATP III-National Cholesterol Education Program third Adult Treatment Panel.
